nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—germ cell cancer—melanoma	0.163	0.359	CtDrD
Etoposide—lung cancer—melanoma	0.147	0.323	CtDrD
Etoposide—sarcoma—melanoma	0.145	0.319	CtDrD
Etoposide—ABCC6—Dactinomycin—melanoma	0.0767	0.257	CbGbCtD
Etoposide—PTGS2—melanoma	0.0591	0.54	CbGaD
Etoposide—ABCB1—melanoma	0.0503	0.46	CbGaD
Etoposide—ABCC1—Vemurafenib—melanoma	0.034	0.114	CbGbCtD
Etoposide—ABCC10—Docetaxel—melanoma	0.0302	0.101	CbGbCtD
Etoposide—ABCG2—Vemurafenib—melanoma	0.0228	0.0762	CbGbCtD
Etoposide—ABCC1—Dactinomycin—melanoma	0.0226	0.0757	CbGbCtD
Etoposide—ABCG2—Dactinomycin—melanoma	0.0151	0.0507	CbGbCtD
Etoposide—CYP2E1—Dacarbazine—melanoma	0.0124	0.0417	CbGbCtD
Etoposide—CYP1A2—Carmustine—melanoma	0.0119	0.0398	CbGbCtD
Etoposide—ABCC1—Docetaxel—melanoma	0.0117	0.0391	CbGbCtD
Etoposide—CYP1A2—Vemurafenib—melanoma	0.00939	0.0314	CbGbCtD
Etoposide—CYP3A4—Temozolomide—melanoma	0.00898	0.0301	CbGbCtD
Etoposide—ABCC2—Docetaxel—melanoma	0.00864	0.0289	CbGbCtD
Etoposide—ABCG2—Docetaxel—melanoma	0.00781	0.0262	CbGbCtD
Etoposide—CYP1A2—Dacarbazine—melanoma	0.0072	0.0241	CbGbCtD
Etoposide—ABCB1—Dactinomycin—melanoma	0.00546	0.0183	CbGbCtD
Etoposide—CYP3A4—Vemurafenib—melanoma	0.00492	0.0165	CbGbCtD
Etoposide—CYP3A5—Docetaxel—melanoma	0.00433	0.0145	CbGbCtD
Etoposide—ABCC6—dermis—melanoma	0.004	0.2	CbGeAlD
Etoposide—ABCB1—Docetaxel—melanoma	0.00282	0.00943	CbGbCtD
Etoposide—CYP3A4—Docetaxel—melanoma	0.00169	0.00565	CbGbCtD
Etoposide—TOP2B—hair follicle—melanoma	0.00109	0.0545	CbGeAlD
Etoposide—GSTT1—neck—melanoma	0.000992	0.0497	CbGeAlD
Etoposide—TOP2A—Paclitaxel—Docetaxel—melanoma	0.000722	1	CbGdCrCtD
Etoposide—PTGS2—leg—melanoma	0.0007	0.0351	CbGeAlD
Etoposide—GSTP1—hair follicle—melanoma	0.000682	0.0342	CbGeAlD
Etoposide—PTGS2—hindlimb—melanoma	0.000625	0.0313	CbGeAlD
Etoposide—ABCC6—eye—melanoma	0.000599	0.03	CbGeAlD
Etoposide—ABCC6—retina—melanoma	0.000594	0.0297	CbGeAlD
Etoposide—TOP2B—eye—melanoma	0.000544	0.0272	CbGeAlD
Etoposide—TOP2B—retina—melanoma	0.000539	0.027	CbGeAlD
Etoposide—PTGS2—appendage—melanoma	0.000536	0.0269	CbGeAlD
Etoposide—ABCC1—hair follicle—melanoma	0.000482	0.0241	CbGeAlD
Etoposide—GSTP1—neck—melanoma	0.000458	0.0229	CbGeAlD
Etoposide—PTGS2—skin epidermis—melanoma	0.000446	0.0223	CbGeAlD
Etoposide—TOP2B—mammalian vulva—melanoma	0.000431	0.0216	CbGeAlD
Etoposide—GSTT1—head—melanoma	0.000419	0.021	CbGeAlD
Etoposide—GSTP1—eye—melanoma	0.000341	0.0171	CbGeAlD
Etoposide—ABCC6—head—melanoma	0.00034	0.017	CbGeAlD
Etoposide—PTGS1—endothelium—melanoma	0.000339	0.017	CbGeAlD
Etoposide—GSTP1—retina—melanoma	0.000338	0.0169	CbGeAlD
Etoposide—PTGS2—endothelium—melanoma	0.000324	0.0162	CbGeAlD
Etoposide—TOP2A—mammalian vulva—melanoma	0.000317	0.0159	CbGeAlD
Etoposide—PTGS1—blood vessel—melanoma	0.000312	0.0156	CbGeAlD
Etoposide—TOP2B—head—melanoma	0.000309	0.0155	CbGeAlD
Etoposide—PTGS2—blood vessel—melanoma	0.000299	0.0149	CbGeAlD
Etoposide—GSTP1—skin of body—melanoma	0.000296	0.0148	CbGeAlD
Etoposide—GSTP1—mammalian vulva—melanoma	0.00027	0.0135	CbGeAlD
Etoposide—ABCC10—mammalian vulva—melanoma	0.00027	0.0135	CbGeAlD
Etoposide—TOP2B—lymph node—melanoma	0.000216	0.0108	CbGeAlD
Etoposide—ABCC3—head—melanoma	0.000194	0.00972	CbGeAlD
Etoposide—GSTP1—head—melanoma	0.000193	0.00968	CbGeAlD
Etoposide—ABCC1—mammalian vulva—melanoma	0.000191	0.00956	CbGeAlD
Etoposide—ABCB1—blood vessel—melanoma	0.000185	0.00925	CbGeAlD
Etoposide—TOP2A—lymph node—melanoma	0.000159	0.00796	CbGeAlD
Etoposide—ABCG2—mammalian vulva—melanoma	0.000158	0.00792	CbGeAlD
Etoposide—Constipation—Vemurafenib—melanoma	0.000148	0.00201	CcSEcCtD
Etoposide—Pancytopenia—Temozolomide—melanoma	0.000148	0.00201	CcSEcCtD
Etoposide—Hypoaesthesia—Bleomycin—melanoma	0.000147	0.002	CcSEcCtD
Etoposide—Neutropenia—Temozolomide—melanoma	0.000146	0.00198	CcSEcCtD
Etoposide—Pneumonia—Carmustine—melanoma	0.000145	0.00196	CcSEcCtD
Etoposide—PTGS1—skin of body—melanoma	0.000145	0.00724	CbGeAlD
Etoposide—Agranulocytosis—Dactinomycin—melanoma	0.000144	0.00195	CcSEcCtD
Etoposide—Sepsis—Docetaxel—melanoma	0.000144	0.00195	CcSEcCtD
Etoposide—Renal failure—Carmustine—melanoma	0.000142	0.00192	CcSEcCtD
Etoposide—Neuropathy peripheral—Carmustine—melanoma	0.000141	0.00191	CcSEcCtD
Etoposide—Stomatitis—Carmustine—melanoma	0.00014	0.0019	CcSEcCtD
Etoposide—Pneumonia—Temozolomide—melanoma	0.00014	0.0019	CcSEcCtD
Etoposide—Phlebitis—Docetaxel—melanoma	0.000139	0.00189	CcSEcCtD
Etoposide—Infestation—Temozolomide—melanoma	0.000139	0.00189	CcSEcCtD
Etoposide—Infestation NOS—Temozolomide—melanoma	0.000139	0.00189	CcSEcCtD
Etoposide—PTGS2—skin of body—melanoma	0.000138	0.00692	CbGeAlD
Etoposide—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000138	0.00187	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000138	0.00187	CcSEcCtD
Etoposide—Flushing—Bleomycin—melanoma	0.000137	0.00186	CcSEcCtD
Etoposide—Body temperature increased—Vemurafenib—melanoma	0.000137	0.00186	CcSEcCtD
Etoposide—Neuropathy peripheral—Temozolomide—melanoma	0.000136	0.00185	CcSEcCtD
Etoposide—Swelling—Docetaxel—melanoma	0.000136	0.00184	CcSEcCtD
Etoposide—ABCC3—lymph node—melanoma	0.000136	0.00681	CbGeAlD
Etoposide—Stomatitis—Temozolomide—melanoma	0.000136	0.00184	CcSEcCtD
Etoposide—GSTP1—lymph node—melanoma	0.000135	0.00678	CbGeAlD
Etoposide—ABCC10—lymph node—melanoma	0.000135	0.00677	CbGeAlD
Etoposide—Chills—Bleomycin—melanoma	0.000133	0.0018	CcSEcCtD
Etoposide—Cardiac failure congestive—Docetaxel—melanoma	0.000132	0.00179	CcSEcCtD
Etoposide—PTGS1—mammalian vulva—melanoma	0.000132	0.0066	CbGeAlD
Etoposide—Hepatobiliary disease—Temozolomide—melanoma	0.000132	0.00178	CcSEcCtD
Etoposide—Alopecia—Bleomycin—melanoma	0.000131	0.00177	CcSEcCtD
Etoposide—Erythema multiforme—Dactinomycin—melanoma	0.000131	0.00177	CcSEcCtD
Etoposide—Hypoaesthesia—Carmustine—melanoma	0.000129	0.00174	CcSEcCtD
Etoposide—Flushing—Dactinomycin—melanoma	0.000128	0.00174	CcSEcCtD
Etoposide—Hypersensitivity—Vemurafenib—melanoma	0.000128	0.00173	CcSEcCtD
Etoposide—Asthenia—Vemurafenib—melanoma	0.000125	0.00169	CcSEcCtD
Etoposide—Hypoaesthesia—Temozolomide—melanoma	0.000124	0.00168	CcSEcCtD
Etoposide—Chills—Dactinomycin—melanoma	0.000124	0.00168	CcSEcCtD
Etoposide—Urinary tract disorder—Temozolomide—melanoma	0.000123	0.00167	CcSEcCtD
Etoposide—Cardiac failure—Docetaxel—melanoma	0.000123	0.00167	CcSEcCtD
Etoposide—Pruritus—Vemurafenib—melanoma	0.000123	0.00167	CcSEcCtD
Etoposide—Urethral disorder—Temozolomide—melanoma	0.000122	0.00166	CcSEcCtD
Etoposide—Alopecia—Dactinomycin—melanoma	0.000122	0.00165	CcSEcCtD
Etoposide—Eye disorder—Carmustine—melanoma	0.000121	0.00164	CcSEcCtD
Etoposide—Flushing—Carmustine—melanoma	0.00012	0.00163	CcSEcCtD
Etoposide—Ill-defined disorder—Bleomycin—melanoma	0.00012	0.00162	CcSEcCtD
Etoposide—Anaemia—Bleomycin—melanoma	0.000119	0.00161	CcSEcCtD
Etoposide—Diarrhoea—Vemurafenib—melanoma	0.000119	0.00161	CcSEcCtD
Etoposide—Erythema multiforme—Temozolomide—melanoma	0.000118	0.0016	CcSEcCtD
Etoposide—Eye disorder—Temozolomide—melanoma	0.000117	0.00158	CcSEcCtD
Etoposide—Malaise—Bleomycin—melanoma	0.000116	0.00158	CcSEcCtD
Etoposide—Flushing—Temozolomide—melanoma	0.000116	0.00157	CcSEcCtD
Etoposide—Cardiac disorder—Temozolomide—melanoma	0.000116	0.00157	CcSEcCtD
Etoposide—Leukopenia—Bleomycin—melanoma	0.000115	0.00156	CcSEcCtD
Etoposide—Dizziness—Vemurafenib—melanoma	0.000115	0.00156	CcSEcCtD
Etoposide—Alopecia—Carmustine—melanoma	0.000114	0.00155	CcSEcCtD
Etoposide—Angiopathy—Temozolomide—melanoma	0.000113	0.00154	CcSEcCtD
Etoposide—Immune system disorder—Temozolomide—melanoma	0.000113	0.00153	CcSEcCtD
Etoposide—Mediastinal disorder—Temozolomide—melanoma	0.000113	0.00153	CcSEcCtD
Etoposide—Cough—Bleomycin—melanoma	0.000112	0.00152	CcSEcCtD
Etoposide—Chills—Temozolomide—melanoma	0.000112	0.00152	CcSEcCtD
Etoposide—Ill-defined disorder—Dactinomycin—melanoma	0.000112	0.00151	CcSEcCtD
Etoposide—Anaemia—Dactinomycin—melanoma	0.000111	0.00151	CcSEcCtD
Etoposide—Vomiting—Vemurafenib—melanoma	0.00011	0.0015	CcSEcCtD
Etoposide—Alopecia—Temozolomide—melanoma	0.00011	0.0015	CcSEcCtD
Etoposide—Chest pain—Bleomycin—melanoma	0.00011	0.00149	CcSEcCtD
Etoposide—Rash—Vemurafenib—melanoma	0.000109	0.00148	CcSEcCtD
Etoposide—Dermatitis—Vemurafenib—melanoma	0.000109	0.00148	CcSEcCtD
Etoposide—Back pain—Carmustine—melanoma	0.000109	0.00148	CcSEcCtD
Etoposide—Headache—Vemurafenib—melanoma	0.000109	0.00147	CcSEcCtD
Etoposide—ABCC2—lymph node—melanoma	0.000109	0.00544	CbGeAlD
Etoposide—Discomfort—Bleomycin—melanoma	0.000108	0.00147	CcSEcCtD
Etoposide—Malaise—Dactinomycin—melanoma	0.000108	0.00147	CcSEcCtD
Etoposide—Cramp muscle—Docetaxel—melanoma	0.000108	0.00147	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000108	0.00147	CcSEcCtD
Etoposide—Leukopenia—Dactinomycin—melanoma	0.000108	0.00146	CcSEcCtD
Etoposide—Dysgeusia—Temozolomide—melanoma	0.000106	0.00144	CcSEcCtD
Etoposide—Confusional state—Bleomycin—melanoma	0.000106	0.00144	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Docetaxel—melanoma	0.000106	0.00144	CcSEcCtD
Etoposide—Anaphylactic shock—Bleomycin—melanoma	0.000105	0.00143	CcSEcCtD
Etoposide—Back pain—Temozolomide—melanoma	0.000105	0.00143	CcSEcCtD
Etoposide—Infection—Bleomycin—melanoma	0.000105	0.00142	CcSEcCtD
Etoposide—Anaemia—Carmustine—melanoma	0.000104	0.00141	CcSEcCtD
Etoposide—Dysphagia—Docetaxel—melanoma	0.000104	0.00141	CcSEcCtD
Etoposide—Nausea—Vemurafenib—melanoma	0.000103	0.0014	CcSEcCtD
Etoposide—Thrombocytopenia—Bleomycin—melanoma	0.000103	0.0014	CcSEcCtD
Etoposide—Bronchospasm—Docetaxel—melanoma	0.000102	0.00138	CcSEcCtD
Etoposide—Discomfort—Dactinomycin—melanoma	0.000101	0.00137	CcSEcCtD
Etoposide—Ill-defined disorder—Temozolomide—melanoma	0.000101	0.00137	CcSEcCtD
Etoposide—Leukopenia—Carmustine—melanoma	0.000101	0.00137	CcSEcCtD
Etoposide—Anaemia—Temozolomide—melanoma	0.0001	0.00136	CcSEcCtD
Etoposide—Anorexia—Bleomycin—melanoma	0.0001	0.00136	CcSEcCtD
Etoposide—Pancytopenia—Docetaxel—melanoma	9.85e-05	0.00134	CcSEcCtD
Etoposide—Hypotension—Bleomycin—melanoma	9.83e-05	0.00133	CcSEcCtD
Etoposide—Malaise—Temozolomide—melanoma	9.8e-05	0.00133	CcSEcCtD
Etoposide—CYP2E1—head—melanoma	9.79e-05	0.0049	CbGeAlD
Etoposide—Vertigo—Temozolomide—melanoma	9.77e-05	0.00132	CcSEcCtD
Etoposide—Convulsion—Carmustine—melanoma	9.75e-05	0.00132	CcSEcCtD
Etoposide—Infection—Dactinomycin—melanoma	9.75e-05	0.00132	CcSEcCtD
Etoposide—ABCB1—retina—melanoma	9.74e-05	0.00488	CbGeAlD
Etoposide—Leukopenia—Temozolomide—melanoma	9.73e-05	0.00132	CcSEcCtD
Etoposide—Hypertension—Carmustine—melanoma	9.71e-05	0.00132	CcSEcCtD
Etoposide—Neutropenia—Docetaxel—melanoma	9.7e-05	0.00132	CcSEcCtD
Etoposide—Thrombocytopenia—Dactinomycin—melanoma	9.61e-05	0.0013	CcSEcCtD
Etoposide—Chest pain—Carmustine—melanoma	9.58e-05	0.0013	CcSEcCtD
Etoposide—ABCC1—lymph node—melanoma	9.57e-05	0.00479	CbGeAlD
Etoposide—Cough—Temozolomide—melanoma	9.49e-05	0.00129	CcSEcCtD
Etoposide—Paraesthesia—Bleomycin—melanoma	9.45e-05	0.00128	CcSEcCtD
Etoposide—PTGS1—head—melanoma	9.44e-05	0.00472	CbGeAlD
Etoposide—Convulsion—Temozolomide—melanoma	9.42e-05	0.00128	CcSEcCtD
Etoposide—Hypertension—Temozolomide—melanoma	9.39e-05	0.00127	CcSEcCtD
Etoposide—Dyspnoea—Bleomycin—melanoma	9.38e-05	0.00127	CcSEcCtD
Etoposide—Anorexia—Dactinomycin—melanoma	9.35e-05	0.00127	CcSEcCtD
Etoposide—Pneumonia—Docetaxel—melanoma	9.31e-05	0.00126	CcSEcCtD
Etoposide—Confusional state—Carmustine—melanoma	9.26e-05	0.00126	CcSEcCtD
Etoposide—Infestation NOS—Docetaxel—melanoma	9.25e-05	0.00125	CcSEcCtD
Etoposide—Infestation—Docetaxel—melanoma	9.25e-05	0.00125	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	9.19e-05	0.00125	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Docetaxel—melanoma	9.17e-05	0.00124	CcSEcCtD
Etoposide—Discomfort—Temozolomide—melanoma	9.15e-05	0.00124	CcSEcCtD
Etoposide—Decreased appetite—Bleomycin—melanoma	9.14e-05	0.00124	CcSEcCtD
Etoposide—Infection—Carmustine—melanoma	9.12e-05	0.00124	CcSEcCtD
Etoposide—Acute coronary syndrome—Docetaxel—melanoma	9.12e-05	0.00124	CcSEcCtD
Etoposide—Renal failure—Docetaxel—melanoma	9.1e-05	0.00123	CcSEcCtD
Etoposide—Neuropathy peripheral—Docetaxel—melanoma	9.07e-05	0.00123	CcSEcCtD
Etoposide—Myocardial infarction—Docetaxel—melanoma	9.07e-05	0.00123	CcSEcCtD
Etoposide—PTGS2—head—melanoma	9.02e-05	0.00452	CbGeAlD
Etoposide—Stomatitis—Docetaxel—melanoma	9.02e-05	0.00122	CcSEcCtD
Etoposide—Jaundice—Docetaxel—melanoma	9.02e-05	0.00122	CcSEcCtD
Etoposide—Pain—Bleomycin—melanoma	9e-05	0.00122	CcSEcCtD
Etoposide—Thrombocytopenia—Carmustine—melanoma	8.99e-05	0.00122	CcSEcCtD
Etoposide—Tachycardia—Carmustine—melanoma	8.96e-05	0.00121	CcSEcCtD
Etoposide—Confusional state—Temozolomide—melanoma	8.95e-05	0.00121	CcSEcCtD
Etoposide—Anaphylactic shock—Temozolomide—melanoma	8.87e-05	0.0012	CcSEcCtD
Etoposide—Infection—Temozolomide—melanoma	8.82e-05	0.0012	CcSEcCtD
Etoposide—Anorexia—Carmustine—melanoma	8.75e-05	0.00119	CcSEcCtD
Etoposide—Hepatobiliary disease—Docetaxel—melanoma	8.75e-05	0.00119	CcSEcCtD
Etoposide—Thrombocytopenia—Temozolomide—melanoma	8.69e-05	0.00118	CcSEcCtD
Etoposide—Feeling abnormal—Bleomycin—melanoma	8.67e-05	0.00118	CcSEcCtD
Etoposide—Agranulocytosis—Docetaxel—melanoma	8.63e-05	0.00117	CcSEcCtD
Etoposide—Skin disorder—Temozolomide—melanoma	8.62e-05	0.00117	CcSEcCtD
Etoposide—Hypotension—Carmustine—melanoma	8.58e-05	0.00116	CcSEcCtD
Etoposide—Hyperhidrosis—Temozolomide—melanoma	8.58e-05	0.00116	CcSEcCtD
Etoposide—Decreased appetite—Dactinomycin—melanoma	8.53e-05	0.00116	CcSEcCtD
Etoposide—Fatigue—Dactinomycin—melanoma	8.46e-05	0.00115	CcSEcCtD
Etoposide—Anorexia—Temozolomide—melanoma	8.46e-05	0.00115	CcSEcCtD
Etoposide—Pain—Dactinomycin—melanoma	8.39e-05	0.00114	CcSEcCtD
Etoposide—Urticaria—Bleomycin—melanoma	8.36e-05	0.00113	CcSEcCtD
Etoposide—Body temperature increased—Bleomycin—melanoma	8.32e-05	0.00113	CcSEcCtD
Etoposide—Hypoaesthesia—Docetaxel—melanoma	8.26e-05	0.00112	CcSEcCtD
Etoposide—Paraesthesia—Carmustine—melanoma	8.25e-05	0.00112	CcSEcCtD
Etoposide—Urinary tract disorder—Docetaxel—melanoma	8.2e-05	0.00111	CcSEcCtD
Etoposide—Dyspnoea—Carmustine—melanoma	8.19e-05	0.00111	CcSEcCtD
Etoposide—Somnolence—Carmustine—melanoma	8.16e-05	0.00111	CcSEcCtD
Etoposide—Urethral disorder—Docetaxel—melanoma	8.14e-05	0.0011	CcSEcCtD
Etoposide—Feeling abnormal—Dactinomycin—melanoma	8.08e-05	0.0011	CcSEcCtD
Etoposide—Gastrointestinal pain—Dactinomycin—melanoma	8.02e-05	0.00109	CcSEcCtD
Etoposide—Decreased appetite—Carmustine—melanoma	7.98e-05	0.00108	CcSEcCtD
Etoposide—Paraesthesia—Temozolomide—melanoma	7.97e-05	0.00108	CcSEcCtD
Etoposide—Gastrointestinal disorder—Carmustine—melanoma	7.93e-05	0.00107	CcSEcCtD
Etoposide—ABCG2—lymph node—melanoma	7.92e-05	0.00397	CbGeAlD
Etoposide—Dyspnoea—Temozolomide—melanoma	7.91e-05	0.00107	CcSEcCtD
Etoposide—Somnolence—Temozolomide—melanoma	7.89e-05	0.00107	CcSEcCtD
Etoposide—Erythema multiforme—Docetaxel—melanoma	7.85e-05	0.00106	CcSEcCtD
Etoposide—Constipation—Carmustine—melanoma	7.85e-05	0.00106	CcSEcCtD
Etoposide—Pain—Carmustine—melanoma	7.85e-05	0.00106	CcSEcCtD
Etoposide—ABCB1—mammalian vulva—melanoma	7.8e-05	0.0039	CbGeAlD
Etoposide—Eye disorder—Docetaxel—melanoma	7.76e-05	0.00105	CcSEcCtD
Etoposide—Abdominal pain—Dactinomycin—melanoma	7.76e-05	0.00105	CcSEcCtD
Etoposide—Body temperature increased—Dactinomycin—melanoma	7.76e-05	0.00105	CcSEcCtD
Etoposide—Hypersensitivity—Bleomycin—melanoma	7.75e-05	0.00105	CcSEcCtD
Etoposide—Decreased appetite—Temozolomide—melanoma	7.71e-05	0.00105	CcSEcCtD
Etoposide—Flushing—Docetaxel—melanoma	7.71e-05	0.00104	CcSEcCtD
Etoposide—Cardiac disorder—Docetaxel—melanoma	7.71e-05	0.00104	CcSEcCtD
Etoposide—Gastrointestinal disorder—Temozolomide—melanoma	7.66e-05	0.00104	CcSEcCtD
Etoposide—Fatigue—Temozolomide—melanoma	7.65e-05	0.00104	CcSEcCtD
Etoposide—Pain—Temozolomide—melanoma	7.59e-05	0.00103	CcSEcCtD
Etoposide—Constipation—Temozolomide—melanoma	7.59e-05	0.00103	CcSEcCtD
Etoposide—Feeling abnormal—Carmustine—melanoma	7.57e-05	0.00103	CcSEcCtD
Etoposide—Asthenia—Bleomycin—melanoma	7.55e-05	0.00102	CcSEcCtD
Etoposide—Angiopathy—Docetaxel—melanoma	7.54e-05	0.00102	CcSEcCtD
Etoposide—Gastrointestinal pain—Carmustine—melanoma	7.51e-05	0.00102	CcSEcCtD
Etoposide—Immune system disorder—Docetaxel—melanoma	7.5e-05	0.00102	CcSEcCtD
Etoposide—Mediastinal disorder—Docetaxel—melanoma	7.49e-05	0.00101	CcSEcCtD
Etoposide—Chills—Docetaxel—melanoma	7.45e-05	0.00101	CcSEcCtD
Etoposide—Pruritus—Bleomycin—melanoma	7.44e-05	0.00101	CcSEcCtD
Etoposide—Alopecia—Docetaxel—melanoma	7.34e-05	0.000995	CcSEcCtD
Etoposide—Feeling abnormal—Temozolomide—melanoma	7.31e-05	0.000991	CcSEcCtD
Etoposide—Abdominal pain—Carmustine—melanoma	7.26e-05	0.000984	CcSEcCtD
Etoposide—Body temperature increased—Carmustine—melanoma	7.26e-05	0.000984	CcSEcCtD
Etoposide—Gastrointestinal pain—Temozolomide—melanoma	7.26e-05	0.000984	CcSEcCtD
Etoposide—Hypersensitivity—Dactinomycin—melanoma	7.23e-05	0.00098	CcSEcCtD
Etoposide—Dysgeusia—Docetaxel—melanoma	7.08e-05	0.00096	CcSEcCtD
Etoposide—Urticaria—Temozolomide—melanoma	7.05e-05	0.000956	CcSEcCtD
Etoposide—Asthenia—Dactinomycin—melanoma	7.04e-05	0.000954	CcSEcCtD
Etoposide—Abdominal pain—Temozolomide—melanoma	7.01e-05	0.000951	CcSEcCtD
Etoposide—Body temperature increased—Temozolomide—melanoma	7.01e-05	0.000951	CcSEcCtD
Etoposide—Back pain—Docetaxel—melanoma	6.99e-05	0.000948	CcSEcCtD
Etoposide—Muscle spasms—Docetaxel—melanoma	6.95e-05	0.000942	CcSEcCtD
Etoposide—Hypersensitivity—Carmustine—melanoma	6.77e-05	0.000917	CcSEcCtD
Etoposide—Diarrhoea—Dactinomycin—melanoma	6.71e-05	0.00091	CcSEcCtD
Etoposide—Vomiting—Bleomycin—melanoma	6.69e-05	0.000907	CcSEcCtD
Etoposide—Anaemia—Docetaxel—melanoma	6.68e-05	0.000906	CcSEcCtD
Etoposide—Rash—Bleomycin—melanoma	6.63e-05	0.000899	CcSEcCtD
Etoposide—Dermatitis—Bleomycin—melanoma	6.63e-05	0.000898	CcSEcCtD
Etoposide—PTGS1—lymph node—melanoma	6.61e-05	0.00331	CbGeAlD
Etoposide—Asthenia—Carmustine—melanoma	6.59e-05	0.000893	CcSEcCtD
Etoposide—Hypersensitivity—Temozolomide—melanoma	6.54e-05	0.000886	CcSEcCtD
Etoposide—Leukopenia—Docetaxel—melanoma	6.47e-05	0.000877	CcSEcCtD
Etoposide—Asthenia—Temozolomide—melanoma	6.37e-05	0.000863	CcSEcCtD
Etoposide—Loss of consciousness—Docetaxel—melanoma	6.36e-05	0.000861	CcSEcCtD
Etoposide—PTGS2—lymph node—melanoma	6.32e-05	0.00316	CbGeAlD
Etoposide—Cough—Docetaxel—melanoma	6.31e-05	0.000855	CcSEcCtD
Etoposide—Diarrhoea—Carmustine—melanoma	6.28e-05	0.000852	CcSEcCtD
Etoposide—Pruritus—Temozolomide—melanoma	6.28e-05	0.000851	CcSEcCtD
Etoposide—Convulsion—Docetaxel—melanoma	6.26e-05	0.000849	CcSEcCtD
Etoposide—Nausea—Bleomycin—melanoma	6.25e-05	0.000847	CcSEcCtD
Etoposide—Hypertension—Docetaxel—melanoma	6.24e-05	0.000846	CcSEcCtD
Etoposide—Vomiting—Dactinomycin—melanoma	6.24e-05	0.000846	CcSEcCtD
Etoposide—Rash—Dactinomycin—melanoma	6.19e-05	0.000839	CcSEcCtD
Etoposide—Chest pain—Docetaxel—melanoma	6.16e-05	0.000834	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	6.11e-05	0.000829	CcSEcCtD
Etoposide—Dizziness—Carmustine—melanoma	6.07e-05	0.000823	CcSEcCtD
Etoposide—Diarrhoea—Temozolomide—melanoma	6.07e-05	0.000823	CcSEcCtD
Etoposide—Confusional state—Docetaxel—melanoma	5.95e-05	0.000807	CcSEcCtD
Etoposide—Anaphylactic shock—Docetaxel—melanoma	5.9e-05	0.0008	CcSEcCtD
Etoposide—Dizziness—Temozolomide—melanoma	5.87e-05	0.000795	CcSEcCtD
Etoposide—Infection—Docetaxel—melanoma	5.86e-05	0.000795	CcSEcCtD
Etoposide—Vomiting—Carmustine—melanoma	5.84e-05	0.000791	CcSEcCtD
Etoposide—Nausea—Dactinomycin—melanoma	5.83e-05	0.00079	CcSEcCtD
Etoposide—Rash—Carmustine—melanoma	5.79e-05	0.000785	CcSEcCtD
Etoposide—Dermatitis—Carmustine—melanoma	5.78e-05	0.000784	CcSEcCtD
Etoposide—Thrombocytopenia—Docetaxel—melanoma	5.78e-05	0.000783	CcSEcCtD
Etoposide—Tachycardia—Docetaxel—melanoma	5.76e-05	0.000781	CcSEcCtD
Etoposide—Headache—Carmustine—melanoma	5.75e-05	0.00078	CcSEcCtD
Etoposide—Skin disorder—Docetaxel—melanoma	5.73e-05	0.000777	CcSEcCtD
Etoposide—Vomiting—Temozolomide—melanoma	5.64e-05	0.000765	CcSEcCtD
Etoposide—Anorexia—Docetaxel—melanoma	5.63e-05	0.000762	CcSEcCtD
Etoposide—Rash—Temozolomide—melanoma	5.59e-05	0.000758	CcSEcCtD
Etoposide—Dermatitis—Temozolomide—melanoma	5.59e-05	0.000758	CcSEcCtD
Etoposide—ABCB1—head—melanoma	5.58e-05	0.00279	CbGeAlD
Etoposide—Headache—Temozolomide—melanoma	5.56e-05	0.000754	CcSEcCtD
Etoposide—Hypotension—Docetaxel—melanoma	5.51e-05	0.000747	CcSEcCtD
Etoposide—Nausea—Carmustine—melanoma	5.45e-05	0.000739	CcSEcCtD
Etoposide—Paraesthesia—Docetaxel—melanoma	5.3e-05	0.000718	CcSEcCtD
Etoposide—Nausea—Temozolomide—melanoma	5.27e-05	0.000714	CcSEcCtD
Etoposide—Dyspnoea—Docetaxel—melanoma	5.26e-05	0.000713	CcSEcCtD
Etoposide—Somnolence—Docetaxel—melanoma	5.25e-05	0.000711	CcSEcCtD
Etoposide—Decreased appetite—Docetaxel—melanoma	5.13e-05	0.000695	CcSEcCtD
Etoposide—Gastrointestinal disorder—Docetaxel—melanoma	5.09e-05	0.000691	CcSEcCtD
Etoposide—Fatigue—Docetaxel—melanoma	5.09e-05	0.00069	CcSEcCtD
Etoposide—Pain—Docetaxel—melanoma	5.05e-05	0.000684	CcSEcCtD
Etoposide—Constipation—Docetaxel—melanoma	5.05e-05	0.000684	CcSEcCtD
Etoposide—Feeling abnormal—Docetaxel—melanoma	4.86e-05	0.000659	CcSEcCtD
Etoposide—Gastrointestinal pain—Docetaxel—melanoma	4.83e-05	0.000654	CcSEcCtD
Etoposide—Abdominal pain—Docetaxel—melanoma	4.66e-05	0.000632	CcSEcCtD
Etoposide—Body temperature increased—Docetaxel—melanoma	4.66e-05	0.000632	CcSEcCtD
Etoposide—Hypersensitivity—Docetaxel—melanoma	4.35e-05	0.000589	CcSEcCtD
Etoposide—Asthenia—Docetaxel—melanoma	4.23e-05	0.000574	CcSEcCtD
Etoposide—Pruritus—Docetaxel—melanoma	4.18e-05	0.000566	CcSEcCtD
Etoposide—Diarrhoea—Docetaxel—melanoma	4.04e-05	0.000547	CcSEcCtD
Etoposide—ABCB1—lymph node—melanoma	3.91e-05	0.00196	CbGeAlD
Etoposide—Dizziness—Docetaxel—melanoma	3.9e-05	0.000529	CcSEcCtD
Etoposide—Vomiting—Docetaxel—melanoma	3.75e-05	0.000509	CcSEcCtD
Etoposide—Rash—Docetaxel—melanoma	3.72e-05	0.000504	CcSEcCtD
Etoposide—Dermatitis—Docetaxel—melanoma	3.72e-05	0.000504	CcSEcCtD
Etoposide—Headache—Docetaxel—melanoma	3.7e-05	0.000501	CcSEcCtD
Etoposide—Nausea—Docetaxel—melanoma	3.51e-05	0.000475	CcSEcCtD
Etoposide—CYP2C8—Metabolism—CYP17A1—melanoma	2.8e-06	6.53e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PRKCA—melanoma	2.77e-06	6.45e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.77e-06	6.44e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ERCC2—melanoma	2.75e-06	6.4e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—FGF1—melanoma	2.74e-06	6.38e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP1B1—melanoma	2.73e-06	6.36e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	2.73e-06	6.36e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP1B1—melanoma	2.73e-06	6.35e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAP2K1—melanoma	2.71e-06	6.31e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CD—melanoma	2.69e-06	6.27e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.69e-06	6.27e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CG—melanoma	2.66e-06	6.2e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PDGFRA—melanoma	2.65e-06	6.18e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GNA11—melanoma	2.65e-06	6.17e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PRKCA—melanoma	2.63e-06	6.11e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—ERCC2—melanoma	2.6e-06	6.06e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—LUM—melanoma	2.59e-06	6.04e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PHGDH—melanoma	2.59e-06	6.04e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—FASN—melanoma	2.59e-06	6.04e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—FGF2—melanoma	2.58e-06	6.01e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PLA2G6—melanoma	2.57e-06	5.99e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PPARG—melanoma	2.57e-06	5.98e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAP2K2—melanoma	2.57e-06	5.98e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CG—melanoma	2.57e-06	5.98e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.56e-06	5.96e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—SLC5A5—melanoma	2.55e-06	5.94e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HPSE—melanoma	2.54e-06	5.92e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CB—melanoma	2.51e-06	5.84e-05	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.51e-06	5.83e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CUBN—melanoma	2.5e-06	5.82e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTGS2—melanoma	2.49e-06	5.79e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PPARG—melanoma	2.48e-06	5.77e-05	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PIK3CA—melanoma	2.48e-06	5.77e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GNAQ—melanoma	2.46e-06	5.73e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CD44—melanoma	2.46e-06	5.73e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP17A1—melanoma	2.44e-06	5.69e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—TERT—melanoma	2.44e-06	5.68e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HLA-A—melanoma	2.44e-06	5.68e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—RAC1—melanoma	2.43e-06	5.67e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MDM2—melanoma	2.41e-06	5.62e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—BSG—melanoma	2.41e-06	5.62e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SDHD—melanoma	2.41e-06	5.62e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CSPG4—melanoma	2.41e-06	5.62e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.41e-06	5.61e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ABCB1—melanoma	2.39e-06	5.56e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.39e-06	5.56e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—ERBB2—melanoma	2.38e-06	5.54e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP1B1—melanoma	2.36e-06	5.5e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CB—melanoma	2.35e-06	5.47e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CD4—melanoma	2.34e-06	5.46e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CD—melanoma	2.34e-06	5.45e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GPAM—melanoma	2.34e-06	5.44e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HIF1A—melanoma	2.33e-06	5.44e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTGS2—melanoma	2.33e-06	5.42e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—VCAN—melanoma	2.31e-06	5.38e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ALB—melanoma	2.31e-06	5.38e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GNA11—melanoma	2.31e-06	5.37e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.28e-06	5.3e-05	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	2.26e-06	5.27e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—FASN—melanoma	2.26e-06	5.26e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CG—melanoma	2.26e-06	5.26e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CD—melanoma	2.26e-06	5.25e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ABCB1—melanoma	2.25e-06	5.24e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ABCB1—melanoma	2.24e-06	5.23e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ALB—melanoma	2.23e-06	5.19e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SLC5A5—melanoma	2.22e-06	5.17e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1B—melanoma	2.2e-06	5.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PRKCA—melanoma	2.2e-06	5.12e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.19e-06	5.1e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ERCC2—melanoma	2.18e-06	5.08e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PPARG—melanoma	2.18e-06	5.07e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CG—melanoma	2.17e-06	5.05e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTEN—melanoma	2.17e-06	5.05e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GNAQ—melanoma	2.15e-06	4.99e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CD44—melanoma	2.15e-06	4.99e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOS2—melanoma	2.12e-06	4.94e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.11e-06	4.92e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOTCH1—melanoma	2.1e-06	4.9e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PPARG—melanoma	2.09e-06	4.88e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.08e-06	4.85e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CTNNB1—melanoma	2.08e-06	4.85e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PRKCA—melanoma	2.07e-06	4.82e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PRKCA—melanoma	2.07e-06	4.81e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD80—melanoma	2.06e-06	4.8e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP1B1—melanoma	2.06e-06	4.79e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—APC—melanoma	2.06e-06	4.79e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—KIT—melanoma	2.06e-06	4.79e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ERCC2—melanoma	2.05e-06	4.78e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ERCC2—melanoma	2.05e-06	4.77e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CB—melanoma	2.04e-06	4.75e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1A—melanoma	2.03e-06	4.73e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGF—melanoma	2.03e-06	4.73e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTEN—melanoma	2.03e-06	4.72e-05	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—melanoma	2.02e-06	4.71e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—melanoma	2.02e-06	4.7e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PLA2G6—melanoma	1.99e-06	4.63e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CD—melanoma	1.99e-06	4.62e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CB—melanoma	1.97e-06	4.58e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ALB—melanoma	1.96e-06	4.56e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP17A1—melanoma	1.95e-06	4.54e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—melanoma	1.95e-06	4.54e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ABCB1—melanoma	1.94e-06	4.53e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—BRAF—melanoma	1.93e-06	4.5e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.92e-06	4.48e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CD—melanoma	1.91e-06	4.44e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.9e-06	4.42e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ALB—melanoma	1.88e-06	4.38e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GNA11—melanoma	1.84e-06	4.29e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAP2K1—melanoma	1.82e-06	4.24e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—STAT3—melanoma	1.81e-06	4.22e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—NRAS—melanoma	1.81e-06	4.21e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CD—melanoma	1.81e-06	4.21e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.81e-06	4.21e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—FASN—melanoma	1.8e-06	4.2e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PRKCA—melanoma	1.79e-06	4.17e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—VCAN—melanoma	1.78e-06	4.15e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ERCC2—melanoma	1.77e-06	4.13e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SLC5A5—melanoma	1.77e-06	4.13e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTEN—melanoma	1.76e-06	4.1e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK3—melanoma	1.73e-06	4.04e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—FGF2—melanoma	1.73e-06	4.03e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CB—melanoma	1.73e-06	4.03e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CG—melanoma	1.72e-06	4.01e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—melanoma	1.71e-06	3.99e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GNAQ—melanoma	1.71e-06	3.99e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CD44—melanoma	1.71e-06	3.99e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTEN—melanoma	1.7e-06	3.96e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—melanoma	1.69e-06	3.93e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.68e-06	3.9e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CB—melanoma	1.66e-06	3.87e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PPARG—melanoma	1.66e-06	3.87e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.66e-06	3.87e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAPK1—melanoma	1.65e-06	3.84e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—EGFR—melanoma	1.65e-06	3.84e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—melanoma	1.65e-06	3.84e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP1B1—melanoma	1.64e-06	3.82e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CG—melanoma	1.62e-06	3.77e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MDM2—melanoma	1.62e-06	3.77e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CG—melanoma	1.62e-06	3.77e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—ERBB2—melanoma	1.6e-06	3.72e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CB—melanoma	1.58e-06	3.67e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CD4—melanoma	1.57e-06	3.66e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PPARG—melanoma	1.56e-06	3.64e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PPARG—melanoma	1.56e-06	3.64e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PRKCA—melanoma	1.56e-06	3.63e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—KRAS—melanoma	1.56e-06	3.63e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ERCC2—melanoma	1.55e-06	3.6e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CA—melanoma	1.53e-06	3.56e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CD—melanoma	1.51e-06	3.53e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP17A1—melanoma	1.51e-06	3.51e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTEN—melanoma	1.5e-06	3.48e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ALB—melanoma	1.49e-06	3.48e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1B—melanoma	1.48e-06	3.44e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.47e-06	3.42e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.45e-06	3.37e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTEN—melanoma	1.44e-06	3.34e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CA—melanoma	1.43e-06	3.33e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CD—melanoma	1.43e-06	3.32e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CD—melanoma	1.42e-06	3.31e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GNA11—melanoma	1.42e-06	3.31e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ALB—melanoma	1.41e-06	3.28e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ALB—melanoma	1.4e-06	3.27e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CG—melanoma	1.4e-06	3.26e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CTNNB1—melanoma	1.4e-06	3.25e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—FASN—melanoma	1.39e-06	3.24e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC5A5—melanoma	1.37e-06	3.19e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1A—melanoma	1.36e-06	3.18e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PTEN—melanoma	1.36e-06	3.17e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PPARG—melanoma	1.35e-06	3.15e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ABCB1—melanoma	1.35e-06	3.15e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—melanoma	1.32e-06	3.08e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GNAQ—melanoma	1.32e-06	3.08e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CD44—melanoma	1.32e-06	3.08e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CB—melanoma	1.32e-06	3.07e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6—melanoma	1.27e-06	2.95e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1B1—melanoma	1.27e-06	2.95e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—melanoma	1.25e-06	2.91e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PRKCA—melanoma	1.24e-06	2.9e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CA—melanoma	1.24e-06	2.89e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CB—melanoma	1.24e-06	2.89e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CB—melanoma	1.24e-06	2.89e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ERCC2—melanoma	1.23e-06	2.87e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CD—melanoma	1.23e-06	2.87e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—melanoma	1.23e-06	2.87e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—melanoma	1.23e-06	2.86e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CG—melanoma	1.22e-06	2.84e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—STAT3—melanoma	1.22e-06	2.84e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ALB—melanoma	1.22e-06	2.83e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NRAS—melanoma	1.21e-06	2.83e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CA—melanoma	1.2e-06	2.79e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PPARG—melanoma	1.18e-06	2.74e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—melanoma	1.17e-06	2.72e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK3—melanoma	1.16e-06	2.71e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PTEN—melanoma	1.14e-06	2.66e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—melanoma	1.13e-06	2.63e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAPK1—melanoma	1.11e-06	2.58e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGFR—melanoma	1.11e-06	2.58e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CB—melanoma	1.07e-06	2.5e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTEN—melanoma	1.07e-06	2.5e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CD—melanoma	1.07e-06	2.5e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTEN—melanoma	1.07e-06	2.49e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—melanoma	1.06e-06	2.48e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALB—melanoma	1.06e-06	2.47e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CA—melanoma	1.05e-06	2.46e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—KRAS—melanoma	1.05e-06	2.43e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCB1—melanoma	1.04e-06	2.43e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.02e-06	2.38e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—melanoma	1.02e-06	2.36e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CA—melanoma	1.01e-06	2.36e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—melanoma	9.79e-07	2.28e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CG—melanoma	9.75e-07	2.27e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CA—melanoma	9.61e-07	2.24e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PRKCA—melanoma	9.6e-07	2.24e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ERCC2—melanoma	9.52e-07	2.22e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPARG—melanoma	9.41e-07	2.19e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CB—melanoma	9.35e-07	2.18e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTEN—melanoma	9.28e-07	2.16e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—melanoma	9.27e-07	2.16e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—melanoma	8.89e-07	2.07e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—melanoma	8.62e-07	2.01e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CD—melanoma	8.57e-07	1.99e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6—melanoma	8.51e-07	1.98e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALB—melanoma	8.46e-07	1.97e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—melanoma	8.28e-07	1.93e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTEN—melanoma	8.08e-07	1.88e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CA—melanoma	8.04e-07	1.87e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—melanoma	7.85e-07	1.83e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CA—melanoma	7.57e-07	1.76e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CA—melanoma	7.56e-07	1.76e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CG—melanoma	7.52e-07	1.75e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CB—melanoma	7.47e-07	1.74e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—melanoma	7.4e-07	1.72e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPARG—melanoma	7.26e-07	1.69e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CD—melanoma	6.61e-07	1.54e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—melanoma	6.57e-07	1.53e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CA—melanoma	6.55e-07	1.52e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALB—melanoma	6.53e-07	1.52e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTEN—melanoma	6.45e-07	1.5e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—melanoma	6.19e-07	1.44e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—melanoma	6.17e-07	1.44e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CB—melanoma	5.76e-07	1.34e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—melanoma	5.71e-07	1.33e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CA—melanoma	5.7e-07	1.33e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—melanoma	5.35e-07	1.25e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTEN—melanoma	4.98e-07	1.16e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—melanoma	4.66e-07	1.08e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CA—melanoma	4.55e-07	1.06e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—melanoma	3.72e-07	8.66e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CA—melanoma	3.51e-07	8.18e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—melanoma	2.87e-07	6.68e-06	CbGpPWpGaD
